Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Zelapar receives approval recommendation in U.K.

July 23, 1998

Phase III clinical trial results with galantamine suggest novel mechanism of action

July 23, 1998

Nortran initiates phase II trials for local anesthetic

July 23, 1998

New series of neuroprotective compounds described by Nippon Chemiphar

July 23, 1998

Inhaled analgesic available for licensing from BTG

July 23, 1998

Neurogen's epilepsy compound advances through clinical trials

July 22, 1998

Patient dosing begins in phase Ib trial of stroke drug from NPS

July 22, 1998

FDA clears SSRI for depression

July 22, 1998

Preclinical results point to anxiolytic efficacy for Yoshitomi benzodiazepine

July 22, 1998

Analgesic effects of dosulepin in patients with cancer-related pain

July 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...